Investor Relations

Upcoming Events

Annual Meeting of Stockholders

Dec 17, 2021 • 9:00am EST

View All Events

Latest Financial Results

Q2 2022

Quarter Ended Sep 30, 2021

Latest Annual Filing

Fiscal Year Ended Mar 31, 2021

View Filing

Stock Information

Company Overview

BIONIK is a global pioneering healthcare company on a mission to supply quality-of-life solutions to those with movement impairments.  Our goal is to enable the growing millions of people with movement-impairments to lead fuller and more independent lives by fostering hope, recovery and independence with evidence-based technologies, spanning the continuum of rehabilitation care.

The Company’s product portfolio includes three InMotion® Robots for rehabilitation following stroke and other neurological conditions and four products in varying stages of development. Resulting from groundbreaking research at the Newman Laboratory for Biomechanics and Human Rehabilitation at the Massachusetts Institute of Technology (MIT), the InMotion® Robots provide effective, patient-adaptive therapy, intended to restore upper-extremity motor control for a broad range of neurological conditions and recovery stages, including early recovery from acute stroke.

The InMotion® Robots also provide objective evaluation assessments intended to measure and report the patient’s level of motor impairment and progress during the course of therapy. A home version of the InMotion® upper-extremity technology is in development, as well as a wearable, lower-extremity, assistive product based on the company’s ARKE exoskeleton technology. Targeted for the consumer market, the ARKE-based assistive device is intended to help certain individuals walk better.

BIONIK Company Presentation - January 2019

BIONIK Company Presentation - January 2019

Download BIONIK Company Presentation - January 2019


Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information


BIONIK Laboratories Corp.
483 Bay Street
Office N105
Toronto, ON M5G 2C9
T: 416-640-7887

Investor Relations

Richard Russo, Jr., CPA
Chief Financial Officer

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436